Bin Ye Email & Phone Number

1. To advance drug development pipelines in early phase Trials through Biomarker And RD planning and implementation;2. To integrate the Biomarker data derived preclinical models, including PDx, primary cell culture combined with the early phase trials to understand better of the innovative Drug target, MOA, safety and efficacy.3. Outsourcing planning and implementation under GCP/GLP standards. 4. NGS technology including whole genome sequence, Cancer driver gene panel, nanostring immune pathway gene expression, ADME, pathway based Biomarker networking and informatics discovery. 5. Collaborative Research on Drug combination, Biomarkers clinical trial partnership with Clinical KOL, advanced HCC patients and prestigious immune oncology labs.